AbbVie Gastroenterology Pipeline to be Featured at the 16th Congress of European Crohn's and Colitis Organisation Biotech Investing
Kite Announces Yescarta® CAR T-cell Therapy Improved Event-Free Survival by 60% Over Chemotherapy Plus Stem Cell Transplant in Second-Line Relapsed or Refractory Large B-cell Lymphoma Biotech Investing
AbbVie Provides Update Regarding RINVOQ® in Psoriatic Arthritis and Ankylosing Spondylitis in the U.S. Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma for Relapsed and Refractory Multiple Myeloma Biotech Investing
Aurinia Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application for Voclosporin with the European Medicines Agency Biotech Investing
Treatment With Hepcludex® Was Shown to Achieve Significant Response in Chronic Hepatitis Delta Virus After 24 Weeks Biotech Investing
AbbVie Exercises Right to Acquire TeneoOne and Lead Asset TNB-383B for the Potential Treatment of Relapsed or Refractory Multiple Myeloma Biotech Investing
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 Biotech Investing
Wellteq Strengthens Collaboration With Garmin to Counter New COVID Surges in the Asia Pacific Region Biotech Investing
